LendersJ.W., PacakK., WaltherM.M.. Biochemical diagnosis of pheochromocytoma: which test is best?JAMA2002; 287: 1427–34
2.
BrownM.J., AllisonD.J., JennerD.A., LewisP.J., DolleryC.T.Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test.Lancet1981; 1: 174–7
3.
IliasI., PacakK.Current approaches and recommended algorithms for the diagnostic localization of pheochromocytoma.J Clin Endocrinol Metab2004; 89: 479–91
4.
BoulouxP.M., FeatherstoneR.M., Clement-JonesV., ReesL.H., GoligherJ.E.Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.J R Soc Med1985; 78: 588–9
5.
MazeyR.M., KotchenT.A., ErnstC.B.A syndrome resembling pheochromocytoma following a stroke.JAMA1974; 230: 575–7
6.
ZipserR.D., DavenportM.W., MartinK.L.. Hyperreninemic hypoaldosteronism in the critically ill: a new entity.J Clin Endocrinol Metab1981; 53: 867–73
7.
VasanR.S., EvansJ.C., LarsonM.G.. Serum aldosterone and the incidence of hypertension in nonhypertensive persons.N Engl J Med2004; 351: 33–41
PostW.S., HillM.N., DennisonC.R., WeissJ.L., GerstenblithG., BlumenthalR.S.High prevalence of target organ damage in young, African American inner-city men with hypertension.J Clin Hypertens (Greenwich)2003; 5: 24–30